Clinical trial
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally…
NCT00154804 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00154804 |
|---|---|
| Title | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer |
| Official title | A Phase II Study of Concurrent Chemoradiotherapy With Twice Weekly Paclitaxel and Cisplatin (Twice Weekly TP) Followed by Surgery for Locally Advanced Esophageal Cancer |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Cisplatin, Surgery, CCRT |
| Enrollment | 40 |
| Start date | Aug 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 23, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: